There are actually rare post-marketing studies of cases of intestinal obstruction, and exacerbation of diverticulitis, some of which have needed medical intervention to remove the tablet. Patients with fundamental GI Problems including esophageal cancer or colon cancer with a small gastrointestinal lumen are at higher danger of developing these pro